Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $5.2350 (-7.67%) ($5.2350 - $5.2350) on Fri. Jun. 10, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.03% (three month average) | RSI | 53 | Latest Price | $5.2350(-7.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.4% a day on average for past five trading days. | Weekly Trend | ATRA advances 6.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(40%) IBB(37%) ARKK(35%) ARKG(34%) XAR(32%) | Factors Impacting ATRA price | ATRA will decline at least -2.515% in a week (0% probabilities). VIXM(-37%) VXX(-26%) UNG(-24%) USO(-19%) XOP(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.515% (StdDev 5.03%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.53(-5.33%) | 10 Day Moving Average | $5.3(-1.23%) | 20 Day Moving Average | $5.2(0.67%) | To recent high | -46.9% | To recent low | 11.6% | Market Cap | $389m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |